In Vitro Activities Of New Quinolones Against Brucella Melitensis Isolated In A Tertiary-Care Hospital In Turkey

dc.contributor.author	Kocagoz, S
dc.contributor.author	Akova, M
dc.contributor.author	Altun, B
dc.contributor.author	Gur, D
dc.contributor.author	Hascelik, G
dc.date.accessioned	2019-12-10T11:14:06Z
dc.date.available	2019-12-10T11:14:06Z
dc.date.issued	2002
dc.identifier.issn	1198-743X
dc.identifier.uri	https://doi.org/10.1046/j.1469-0691.2002.00416.x
dc.identifier.uri	http://hdl.handle.net/11655/15129
dc.description.abstract	We have evaluated the in vitro activities of seven fluoroquinolones against 69 strains of Brucella melitensis . According to their minimum inhibitory concentration for 90% growth (MIC90 ) values, the most active agent was found to be sparfloxacin (MIC90 0.12 mg/L) followed by levofloxacin, ciprofloxacin, ofloxacin (MIC90 0.50 mg/L) and grepafloxacin (MIC90 1 mg/L), gemifloxacin (MIC90 2 mg/L) and gatifloxacin (MIC90 4 mg/L).
dc.language.iso	en
dc.publisher	Blackwell Publishing Ltd
dc.relation.isversionof	10.1046/j.1469-0691.2002.00416.x
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Infectious Diseases
dc.subject	Microbiology
dc.title	In Vitro Activities Of New Quinolones Against Brucella Melitensis Isolated In A Tertiary-Care Hospital In Turkey
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.relation.journal	Clinical Microbiology And Infection
dc.contributor.department	İç Hastalıkları
dc.identifier.volume	8
dc.identifier.issue	4
dc.identifier.startpage	240
dc.identifier.endpage	242
dc.description.index	WoS
dc.description.index	Scopus